pmc logo image
Logo of postmedjPostgraduate Medical JournalCurrent TOCInstructions for authors
Journal List > Postgrad Med J > v.74(867); Jan 1998

Formats:
Postgrad Med J. 1998 January; 74(867): 45–46.
PMCID: PMC2360778
Copyright notice
Anabolic steroid induced hypogonadism treated with human chorionic gonadotropin.
G. V. Gill
Endocrine Unit, Walton Hospital, Liverpool, UK.
Abstract
A case is presented of a young competitive body-builder who abused anabolic steroid drugs and developed profound symptomatic hypogonadotrophic hypogonadism. With the help of prescribed testosterone (Sustanon) he stopped taking anabolic drugs, and later stopped Sustanon also. Hypogonadism returned, but was successfully treated with weekly injections of human chorionic gonadotropin for three months. Testicular function remained normal thereafter on no treatment. The use of human chorionic gonadotropin should be considered in prolonged hypogonadotrophic hypogonadism due to anabolic steroid abuse.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (374K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
icon of scanned page 45
45
icon of scanned page 46
46
 
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Bagatell CJ, Bremner WJ. Androgens in men--uses and abuses. N Engl J Med. 1996 Mar 14;334(11):707–714. [PubMed]
  • Lamb DR. Anabolic steroids in athletics: how well do they work and how dangerous are they? Am J Sports Med. 1984 Jan–Feb;12(1):31–38. [PubMed]
  • Perry HM, Littlepage BN. Misusing anabolic drugs. BMJ. 1992 Nov 21;305(6864):1241–1242. [PMC free article] [PubMed]
  • Wilson JD. Androgen abuse by athletes. Endocr Rev. 1988 May;9(2):181–199. [PubMed]
  • Wu FC. Testicular steroidogenesis and androgen use and abuse. Baillieres Clin Endocrinol Metab. 1992 Apr;6(2):373–403. [PubMed]
  • McKillop G. Drug abuse in body builders in the West of Scotland. Scott Med J. 1987 Apr;32(2):39–41. [PubMed]
  • Buckley WE, Yesalis CE, 3rd, Friedl KE, Anderson WA, Streit AL, Wright JE. Estimated prevalence of anabolic steroid use among male high school seniors. JAMA. 1988 Dec 16;260(23):3441–3445. [PubMed]
  • Su TP, Pagliaro M, Schmidt PJ, Pickar D, Wolkowitz O, Rubinow DR. Neuropsychiatric effects of anabolic steroids in male normal volunteers. JAMA. 1993 Jun 2;269(21):2760–2764. [PubMed]
  • Martikainen H, Alén M, Rahkila P, Vihko R. Testicular responsiveness to human chorionic gonadotrophin during transient hypogonadotrophic hypogonadism induced by androgenic/anabolic steroids in power athletes. J Steroid Biochem. 1986 Jul;25(1):109–112. [PubMed]
  • Jarow JP, Lipshultz LI. Anabolic steroid-induced hypogonadotropic hypogonadism. Am J Sports Med. 1990 Jul–Aug;18(4):429–431. [PubMed]
Articles from Postgraduate Medical Journal are provided here courtesy of
BMJ Group

PubMed articles by these authors
You are here: NCBI > Literature > PubMed Central
Write to the Help Desk